Clinical Trial Update: REVEAL Biomarkers of Engraftment After Alternative Donor HSCT [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial from the University of Oklahoma is evaluating REVEAL biomarkers of engraftment after alternative donor hematopoietic stem cell transpla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft Failure

Snippet

Sponsor: University of Oklahoma | Conditions: Primary Graft Failure | Phase 1 | Status: RECRUITING